NeoCore Technology Co., Ltd.
4131.TWO
Price:
$38.5
Market Cap:
$1.52B
NeoCore Technology Co., Ltd. designs, manufactures, and sells biochips and rapid nucleic acid hybridization devices. The company's products include food safety examination systems, human diagnosis arrays systems, agriculture examination systems, food examination arrays systems, and laboratory instruments, as well as DNA kits. It also offers laboratory planning, design, and other services. In addition, the company engages in the wholesale and retail of contact lenses. The company was formerly known as DR. Chip Biotechnology Incorporation and changed its name to NeoCore Technology Co., Ltd. in July 2023. NeoCore Technology Co., Ltd. was founded in 1987 and is headquartered in Tainan, Taiwan.
Industry
Biotechnology
IPO Date
2007-12-31
Stock Exchange
TWO
Ticker
4131.TWO
PE Ratio
[-74.04]
ROE
[-5.81%]
Current Ratio
[1.59]
Dividend Yield
[0%]
Enterprise Value
[1.54B]
Dividend History
The ROE as of December 2025 (TTM) for NeoCore Technology Co., Ltd. (4131.TWO) is -5.81%
According to NeoCore Technology Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -5.81%. This represents a change of 292.73% compared to the average of -1.48% of the last 4 quarters.
NeoCore Technology Co., Ltd. (4131.TWO) Historical ROE (quarterly & annually)
How has 4131.TWO ROE performed in the past?
The mean historical ROE of NeoCore Technology Co., Ltd. over the last ten years is -19.29%. The current -5.81% ROE has changed -69.86% with respect to the historical average. Over the past ten years (40 quarters), 4131.TWO's ROE was at its highest in in the June 2025 quarter at 3.87%. The ROE was at its lowest in in the September 2022 quarter at -9.21%.
Average
-19.29%
Median
-17.19%
Minimum
-37.16%
Maximum
-7.91%
NeoCore Technology Co., Ltd. (4131.TWO) ROE by Quarter and Year
Discovering the peaks and valleys of NeoCore Technology Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 165.15%
Maximum Annual ROE = -7.91%
Minimum Annual Increase = -49.96%
Minimum Annual ROE = -37.16%
| Year | ROE | Change |
|---|---|---|
| 2024 | -15.78% | -15.14% |
| 2023 | -18.59% | -49.96% |
| 2022 | -37.16% | 142.12% |
| 2021 | -15.35% | -26.79% |
| 2020 | -20.96% | 165.15% |
NeoCore Technology Co., Ltd. (4131.TWO) Average ROE
How has 4131.TWO ROE performed in the past?
The current ROE of NeoCore Technology Co., Ltd. (4131.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-23.84%
5-year avg
-21.57%
10-year avg
-19.29%
NeoCore Technology Co., Ltd. (4131.TWO) ROE vs. Peers
How is 4131.TWO’s ROE compared to its peers?
NeoCore Technology Co., Ltd.’s ROE is greater than MegaPro Biomedical Co., Ltd (-91.17%), greater than LabTurbo Biotech Corporation (-12.54%), less than Taiwan Advance Bio-Pharmaceutical Inc. (9.19%), greater than GeneReach Biotechnology Corp. (-19.92%), greater than Lukas Biomedical Inc. (-31.59%), greater than Bio Preventive Medicine Corp. (-24.73%), greater than Great Novel Therapeutics Biotech & Medicals (-14.66%), greater than Neith Corporation (-0.50%), less than Level Biotechnology Inc. (12.44%), greater than LAUNXP Biomedical Co., Ltd (-56.54%),
| Company | ROE | Market cap |
|---|---|---|
| -91.17% | $1.02B | |
| -12.54% | $1.12B | |
| 9.19% | $1.05B | |
| -19.92% | $1.10B | |
| -31.59% | $1.33B | |
| -24.73% | $1.14B | |
| -14.66% | $1.48B | |
| -0.50% | $1.22B | |
| 12.44% | $1.08B | |
| -56.54% | $1.12B |
Build a custom stock screener for NeoCore Technology Co., Ltd. (4131.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeoCore Technology Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
NeoCore Technology Co., Ltd. (4131.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like NeoCore Technology Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is NeoCore Technology Co., Ltd.'s ROE?
How is the ROE calculated for NeoCore Technology Co., Ltd. (4131.TWO)?
What is the highest ROE for NeoCore Technology Co., Ltd. (4131.TWO)?
What is the 3-year average ROE for NeoCore Technology Co., Ltd. (4131.TWO)?
What is the 5-year average ROE for NeoCore Technology Co., Ltd. (4131.TWO)?
How does the current ROE for NeoCore Technology Co., Ltd. (4131.TWO) compare to its historical average?